Stay updated on Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Sign up to get notified when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The update appears to be cosmetic UI/layout changes with no changes to the study's core details such as title, conditions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:32:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T07:49:29.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:50:49.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:47:18.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-07T18:18:26.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key medical topics related to multiple sclerosis and various drug classifications have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:26:39.000Z thumbnail image

Stay in the know with updates to Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.